Ascendis Pharma A/S Statistics
NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
252.73-3.23 (-1.26%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ascendis Pharma A/S by the numbers
Ascendis Pharma A/S has a market capitalization of $16.58 billion based on 65.60M shares outstanding. Its trailing P/E ratio is 16.6, below the 4-company peer median of 31.2, and its forward P/E is 20.5. The stock trades 4.2% above its 50-day average and 4.9% above its 200-day average.
Average daily trading volume is 750.65K shares, or about $189.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ASND valuation vs. peer median
| Metric | ASND | Peer median | Difference |
|---|---|---|---|
| Market cap | $16.58B | $14.80B | +12% |
| P/E (TTM) | 16.6 | 31.2 | -47% |
| Forward P/E | 20.5 | 14.5 | +41% |
| Avg. volume | 750.65K | 2.51M | -70% |
Peer median across 8 companies: BBIO, JAZZ, ALNY, ELAN, RDY, BMRN, VTRS, UTHR.
Valuation
- Market cap
- $16.58B
- P/E (TTM)
- 16.62
- Forward P/E
- 20.47
- EPS (TTM)
- $15.21
- Shares outstanding
- 65.60M
Price and trading
- Previous close
- 255.96
- Open
- 255.44
- Day range
- 251.55 – 256.50
- 52-week range
- 188.08 – 282.15
- 52-week change
- +20.07%
- 50-day moving average
- 242.58
- 200-day moving average
- 240.90
- Beta
- —
- Volume
- 602.89K
- Average volume
- 750.65K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 30, 2026
Additional statistics
- Market Cap
- 16.58B
- Pe
- 16.62
- Forward Pe
- 20.47
- Eps
- 15.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 282.15
- Week52 Low
- 188.08
- Avg Volume
- 750.65K
- Shares Outstanding
- 65.60M
- Ma50
- 242.58
- Ma200
- 240.90
- Earnings Date
- Apr 30, 2026
- Pct From52w High
- -10.43%
- Pct From52w Low
- 34.37%